CIK 0000728387
- Non-accelerated filer
- Smaller reporting company
Perspective Therapeutics, Inc.
Sign in to watch- Ticker
- CATX
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 411458152
- Phone
- +1 206-676-0900
- Business address
- 2401 ELLIOTT AVENUE, SUITE 320, SEATTLE, WA, 98121
- Former names
- IsoRay, Inc., Isoray, Inc., CENTURY PARK PICTURES CORP
- 4 Open-market buy CEO bought 150,000 shares at an average $0.40 ($59,295)
- 4 Open-market buy Chief R&D Officer bought 10,000 shares at $0.39 ($3,900)
- 4 Exercise or conversion Dir. of Operations, Secretary acquired 21,900 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 25,000 shares at $0.40 ($10,000)
- 4 Open-market buy Controller/Prin Fin&Acct Offic bought 4,283 shares at $0.40 ($1,703)
- 4 Open-market buy COO, CSO bought 10,000 shares at $0.40 ($4,000)
- 4 Open-market buy Controller/Prin Fin&Acct Offic bought 2,452 shares at $0.41 ($1,005)
- 4 Open-market buy Interim CEO bought 130,000 shares at an average $0.40 ($51,731)
- 4 Open-market buy Director bought 30,000 shares at $0.43 ($12,900)
Page 8 of 17 · 339 filings